Universidade NOVA de Lisboa offers the Master in Medical Microbiology, through four of its Schools: Faculdade de Ciências Médicas|NOVA Medical School (FCM|NMS), Faculdade de Ciências e Tecnologia (FCT NOVA), Instituto de Higiene e Medicina Tropical (IHMT NOVA), and Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA).
The 9th Edition (academic years 2019/2020 and 2020/2021) will be coordinated by FCT NOVA.
Duration: 2 years (4 semesters).
The general objective of the Master in Medical Microbiology is to train students to become experts in the field. It uses a comprehensive and multidisciplinary approach, combining theoretical and practical training, that provides its graduates with capabilities in the application of the most advanced laboratory diagnostics technologies, microbiological testing, inspection and quality assurance in microbiology laboratories.
Advanced training in Medical Microbiology will provide access to a more advanced scientific and technology development corresponding to a PhD (3rd cycle).
It can also provide access to areas of research and development (R&D) in national or European public health sectors, particularly in:
The first semester comprises the mandatory and nuclear Curricular Units.
The second semester is flexible, allowing the selection of 5 optional Curricular Units (out of a group of 16), allowing the student to build a curriculum adapted to his/her needs.
The Curricular Units are mainly taught in Portuguese and have diverse contents. They all have a strong practical component, particularly in the second semester. Attendance to the classes is mandatory and admission to the final assessment depends on attendance of 2/3 of the classes (except for student-workers).
The choice of optional Curricular Units is subject to numerus clausus, and the selection is based on academic performance.
Dedicated to experimental work and preparation of the original Thesis to obtain the Master degree in Medical Microbiology. The theme of the Thesis will be developed in a laboratory in one of the four institutions involved. However, the student is free to select any other laboratory, in Portugal or abroad, after approval of the Scientific Committee and appointment of an internal co-supervisor.
Portuguese students (already enrolled in 2019/20): 2500 €/year
Portuguese students (for those entering 2020/21): 2500 €/year (at IHMT-NOVA)
Foreign students (already enrolled in 2019/20): 7000 €/year
Foreign students (for those entering 2020/21): 2500 €/year (at IHMT-NOVA)
Monday to Thursday (4:00-8:00 pm).
1st Phase: 4th May to 22nd July 2020.
2nd Phase: 18th August to 7th September 2020
Vacancies for 2020/2021:
Edition coordinated by IHMT
Holders of a degree, or equivalent, in Medicine, Veterinary Medicine, Biology, Pharmacy and other areas, as reviewed by the Scientific Committee of the course.
Candidates will be selected and ranked based on the following criteria:
Luís Jaime Mota
Scientific Committee of the course:
Adriano O. Henriques (ITQB NOVA)
Ana Madalena Ludovice (FCT NOVA)
Cecília Maria Arraiano (ITQB NOVA)
Isabel Couto (IHMT NOVA)
João Piedade (IHMT NOVA)
José Paulo Sampaio (FCT NOVA)
Luís Jaime Mota (FCT NOVA)
Maria de Jesus Chasqueira (FCM|NMS)
Maria Miragaia (ITQB NOVA)
Paulo Paixão (FCM|NMS)
Ricardo Parreira (IHMT NOVA)
Registration number R/A-Ef 3114/2011 on 18/03/2011
Accreditation on 02/02/2018, for 6 years
The Department of Life Sciences (Departamento de Ciências da Vida - DCV) focuses its activity on teaching and research in fundamental Biology relevant for application in Biotechnology and Biomedicine.
DCV is responsibel for BSc's Courses - Licenciatura em Biologia Celular e Molecular (1st Cycle), MSc's - Mestrado em Genética molecular e Biomedicina (2nd Cycle) and PhD Program in Biology and PhD Program in Biotechnology (Co-coordination with DQ/FCT/UNL), while collaborating in several other courses with NOVA.
DCV is organised in a single Scientific Section, grouping the scientific ares of Microbiology, Genetics and Cell Biology. Research at DCV is integrated into International and National collaborative efforts in the areas of Microbiology, Human and Molecular Genetics, Biotechnology, Nanobiotechnology and Cell Biology.More info